EGFR and neoplasm: Tumor-associated macrophages (most are M2 macrophages) accelerated cell motility and invasion of myxoid liposarcoma (MLS) cells by activating the EGFR/PI3K/AKT signaling pathway (Nabeshima et al., 2015).